Literature DB >> 8321326

Stimulation of gastrointestinal motility by cisplatin in the ferret: activation of an intrinsic cholinergic mechanism dissociated from emesis.

H I Davidson1, P L Andrews.   

Abstract

Motility was recorded from the corpus, antrum and small intestine of the urethane anaesthetised ferret. The gastrointestinal effects of the highly emetic cytotoxic anticancer agent, cisplatin were investigated following intravenous administration (10 mg/kg i.v.). Following injection, cisplatin induced a prompt onset (< 2 min) increase in motility (tone and contraction amplitude) in all regions with a duration of < 15 min. Acute vagotomy did not abolish the effect but reduced the peak amplitude in the antrum only. Chronic subdiaphragmatic vagotomy significantly enhanced the cisplatin-induced rise in tone in the corpus, the contraction amplitude in the antrum and the duration of the response in the duodenum. The stimulatory effect of cisplatin was blocked in all regions by atropine but not naloxone or the 5-HT3 receptor antagonist ondansetron. This study reports a previously undescribed gastrointestinal motility effect of cisplatin in vivo that is temporally dissociated from emesis. It is proposed that the results provide evidence for a neuroactive effect of cisplatin on enteric cholinergic neurones.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8321326     DOI: 10.1007/bf00166743

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  24 in total

1.  Neuropharmacology of chemotherapy-induced emesis.

Authors:  H L Borison; L E McCarthy
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

2.  Cholinergic role on release and action of motilin.

Authors:  K Y Lee; H J Park; T M Chang; W Y Chey
Journal:  Peptides       Date:  1983 May-Jun       Impact factor: 3.750

3.  Antiemetic properties of the 5HT3-receptor antagonist, GR38032F.

Authors:  R Stables; P L Andrews; H E Bailey; B Costall; S J Gunning; J Hawthorn; R J Naylor; M B Tyers
Journal:  Cancer Treat Rev       Date:  1987-12       Impact factor: 12.111

4.  Effect of cisplatin on myoelectric activity of the stomach and small intestine in dogs.

Authors:  R D Chey; K Y Lee; R Asbury; W Y Chey
Journal:  Dig Dis Sci       Date:  1988-03       Impact factor: 3.199

5.  The role of the abdominal visceral innervation and 5-hydroxytryptamine M-receptors in vomiting induced by the cytotoxic drugs cyclophosphamide and cis-platin in the ferret.

Authors:  J Hawthorn; K J Ostler; P L Andrews
Journal:  Q J Exp Physiol       Date:  1988-01

6.  The gastrointestinal tract in chemotherapy-induced emesis. A final common pathway.

Authors:  O E Akwari
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

7.  5-HT3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret.

Authors:  G A Higgins; G J Kilpatrick; K T Bunce; B J Jones; M B Tyers
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

8.  Vagally mediated gastric motor and emetic reflexes evoked by stimulation of the antral mucosa in anaesthetized ferrets.

Authors:  P L Andrews; K L Wood
Journal:  J Physiol       Date:  1988-01       Impact factor: 5.182

9.  Morphine 6-glucuronide: a metabolite of morphine with greater emetic potency than morphine in the ferret.

Authors:  P I Thompson; S Bingham; P L Andrews; N Patel; S P Joel; M L Slevin
Journal:  Br J Pharmacol       Date:  1992-05       Impact factor: 8.739

10.  [Experimental study on the control of cisplatin-induced emesis in dogs].

Authors:  J Ito; M Okada; T Abo; Y Okamoto; T Yamashita; K Takahashi
Journal:  Gan To Kagaku Ryoho       Date:  1987-03
View more
  4 in total

1.  Cisplatin impairs fluid and electrolyte absorption in rat small intestine: a role for 5-hydroxytryptamine.

Authors:  C P Bearcroft; P Domizio; F H Mourad; E A André; M J Farthing
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

2.  X-ray analysis of the effect of the 5-HT3 receptor antagonist granisetron on gastrointestinal motility in rats repeatedly treated with the antitumoral drug cisplatin.

Authors:  Gema Vera; Ana Esther López-Pérez; María Martínez-Villaluenga; Pablo Antonio Cabezos; Raquel Abalo
Journal:  Exp Brain Res       Date:  2014-05-06       Impact factor: 1.972

3.  Actions of cisplatin on the electrophysiological properties of cultured dorsal root ganglion neurones from neonatal rats.

Authors:  R H Scott; M I Manikon; P L Andrews
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-03       Impact factor: 3.000

Review 4.  Pharmacokinetic considerations in gastrointestinal motor disorders.

Authors:  G S Hebbard; W M Sun; F Bochner; M Horowitz
Journal:  Clin Pharmacokinet       Date:  1995-01       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.